Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Chemotherapy in Recurrent Metastatic Breast Cancer
NCT02489409Phase 2Unknown
- Sponsor
- Xinjiang Medical University
- Start
- Oct 2015
- Primary completion
- May 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in breast cancer, sponsored by Xinjiang Medical University. Status: unknown.
02
Drugs
endostar
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02489409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02489409.